A statistically significantly higher level of activated CD8+ T cells via CD69+ and CD25+ expression was noted in the TILT-322 virus-treated group compared to Ad5/3-E2F-d24-aMUC1aCD3 + T cell, backbone + T cell and tumor + T cell groups (Figures 1F and 1G). This evidence concerns the gene CD69 and neoplasm.